Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

128.55 +0.54 (+0.42%)
Official Closing Price Updated: 7:00 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >
This New ETF Brings Out The Best In S&P 500 Without The Tech Overload
Xtrackers SPXD ETF offers a balanced way to invest in S&P 500 without relying on tech giants like Nvidia. Its innovative approach prioritizes actual economic activity and has affordable fees. 
Via Benzinga
Topics ETFs Stocks
Abbott Laboratories (NYSE:ABT): A High-Quality Dividend Stock with Strong Growth and Financial Health
Via Chartmill
The Smartest Dividend Stocks to Buy With $350 Right Now
These stocks offer juicy dividends, solid growth prospects, and stability. 
Via The Motley Fool
5 Dividend Stocks to Hold for the Next 20 Years
Discover five unstoppable dividend stocks that could pay you for life, and why I wouldn't sell any of them! 
Via The Motley Fool
P/E Ratio Insights for Abbott Laboratories
 
Via Benzinga
What's going on in today's session: S&P500 movers
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
Looking Into Abbott Laboratories's Recent Short Interest
 
Via Benzinga
Invesco, Vistra, Dell, Coinbase Trend In Midday Trade: S&P 500 Hits Record High
Via Stocktwits
Topics Stocks
These S&P500 stocks have an unusual volume in today's session
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below. 
Via Chartmill
Top S&P500 movers in Friday's session
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield
Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity. 
Via MarketBeat
These Analysts Revise Their Forecasts On Abbott Following Q2 Results
 
Via Benzinga
Microsoft To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday
 
Via Benzinga
ABT Q1 Deep Dive: Growth in Devices, Product Pipeline, and Tariff Mitigation Shape Outlook
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of... 
Via StockStory
Topics Economy World Trade
Abbott Reports 12% Growth in Device Sales
Via The Motley Fool
Top S&P500 movers in Thursday's session
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Why Abbott Laboratories (ABT) Shares Are Plunging Today
Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations but... 
Via StockStory
Unusual volume S&P500 stocks in Thursday's session
Let's have a look at the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
Nasdaq 100 Sets New Records, Small Caps Outperform: What's Moving Markets Thursday?
U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor... 
Via Benzinga
Abbott Reports 10.5% EPS Growth for Fiscal Q2
Via The Motley Fool
Topics Economy World Trade
Stay informed with the top movers within the S&P500 index on Thursday.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
Abbott (ABT) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors
Abbott posted Q2 revenue of $11.14 billion and EPS of $1.26, raised 2025 earnings guidance, and saw strong growth in diabetes and heart device sales. 
Via Benzinga
Which S&P500 stocks are gapping on Thursday?
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours
Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said. 
Via Stocktwits
Topics Artificial Intelligence
Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss
The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts. 
Via Investor's Business Daily
Topics Government Stocks
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
Wondering what's happening in today's S&P500 pre-market session?
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers. 
Via Chartmill
Dow Futures Edge Lower As Trump, Powell Feud Escalates, Earnings Take Centerstage: TSMC, PEP, UAL, GE Among Stocks To Watch
While Dow Jones futures were down 0.12% at the time of writing, the S&P 500 futures were up 0.06%. 
Via Stocktwits
Topics ETFs Economy Government
Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.